Crenolanib

Generic Name: Crenolanib

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₂₉N_₅O_₂

CAS Number: 670220-88-9

Unique Ingredient Identifier: LQF7I567TQ

Background: Crenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Relapsed/Refractory Acute Myeloid Leukemia Clinical Trials

DelveInsight's 'Relapsed/refractory acute myeloid leukemia (AML) Pipeline Insight 2024' covers 50+ companies and 75+ pipeline drugs, including clinical and nonclinical stage products, with therapeutic assessments by product type, stage, route of administration, and molecule type. Key companies and therapies highlighted.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy